DEF 14A: ParkerVision Seeks Shareholder Approval for Increased Authorized Common Stock

ParkerVision is asking shareholders to approve an amendment to increase the number of authorized common shares from 175 million to 225 million at the upcoming annual meeting.

Summary

• ParkerVision, Inc. is holding its 2024 annual meeting of shareholders on October 28, 2024.
• Shareholders will vote on four proposals: electing a Class II director, approving an amendment to increase authorized common shares, ratifying the selection of MSL, P.A. as the independent registered public accounting firm, and transacting other business.
• The board of directors has fixed September 3, 2024, as the record date for determining shareholders entitled to vote.
• The company is seeking approval to amend its articles of incorporation to increase the number of authorized common shares from 175,000,000 to 225,000,000.
• As of September 3, 2024, there were 89,673,211 shares of common stock issued and outstanding.
• Additionally, 37,206,190 shares were subject to outstanding options and warrants, 36,467 shares were reserved for issuance under equity compensation plans, and 38,300,571 shares were reserved for issuance upon conversion of outstanding convertible promissory notes.
• The company has retained Advantage Proxy to act as a proxy solicitor for a fee of $4,500 plus expenses.
• The board recommends voting for the election of the director nominee, the amendment to increase authorized shares, and the ratification of the accounting firm.
• The company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, is being sent or made available to shareholders along with the proxy statement.

Sentiment

Score: 6

Explanation: The document is primarily informational, outlining the proposals for the annual meeting. The sentiment is neutral, with a slight positive leaning due to the board's recommendation to vote 'FOR' the proposals and the potential for future growth.

Positives

• The board is actively engaged in risk management and oversight.
• The audit committee and compensation committee are composed entirely of independent directors.
• The company has formalized its non-employee director compensation program.
• The company provides a process for shareholders to communicate with the board.

Negatives

• The company terminated its tax-qualified defined contribution 401(k) plan due to lack of participation.
• The issuance of additional shares of common stock may have a dilutive effect on earnings per share and on the equity and voting power of existing security holders of our capital stock.
• The issuance of additional shares of common stock may adversely affect the market price of the common stock.

Risks

• The company faces risks related to financial performance, intellectual property protection, and market competition.
• The potential issuance of additional shares could dilute existing shareholders' equity and voting power.
• The company's reliance on key personnel poses a risk if they were to leave the company.
• The company's success depends on its ability to protect its intellectual property.

Future Outlook

The company aims to retain flexibility to respond to future business needs and opportunities through the authorization of additional shares of common stock.

Management Comments

• The Board believes approval of the Amendment is in the best interests of the Company and its shareholders.
• The Board believes that combining the roles of Chief Executive Officer and Chairman of the Board promotes leadership and direction for the Board and for executive management, as well as allowing for a single, clear focus for the chain of command.

Industry Context

The document does not provide specific industry context beyond the general need for financial flexibility and strategic opportunities.

Related Party Transactions

• The company paid approximately $52,000 in 2023 for patent-related legal services to SKGF, of which Robert Sterne is a partner.
• The company paid approximately $163,000 in 2023 for principal and interest on an unsecured note payable to SKGF.
• In May 2022, we sold an aggregate of $100,000 in promissory notes, convertible into shares of our common stock at a fixed conversion price of $0.13 to Paul Rosenbaum, one of our directors since December 2016.
• In September 2023, we repaid Mr. Rosenbaum $100,000 upon maturity of a convertible promissory note with a conversion price of $0.40 per share, and we sold Mr. Rosenbaum an additional $100,000 in promissory notes, convertible into shares of our common stock at an above-market fixed conversion price of $0.25.
• In January 2023, Sanford Litvack, one of our directors since October 2022, purchased 62,500 shares of our common stock at $0.16 per share in a private placement transaction.
• In August 2022, we sold an aggregate of $25,000 in promissory notes, convertible into shares of our common stock at a fixed conversion price of $0.13 to Mr. Litvack.
• In April 2023, we entered into a consulting services agreement with Lewis Titterton to provide short-term advisory services to our chief executive officer in connection with the restructuring of the Brickell funding agreements.
• Between 2018 and 2022, Mr. Titterton purchased an aggregate of $425,000 in promissory notes, convertible into shares of common stock at various prices.
• In September 2023, we repaid Mr. Titterton $100,000 upon maturity of a convertible promissory note with a conversion price of $0.40 per share.

Stakeholder Impact

• Shareholders will be impacted by the decisions made at the annual meeting, particularly regarding the increase in authorized shares.
• Employees may be impacted by the use of additional shares for compensation and retention.
• The company's financial flexibility could impact its ability to pursue strategic opportunities, affecting customers and suppliers.

Next Steps

• Shareholders need to vote on the proposals outlined in the proxy statement.
• The company will hold its annual meeting on October 28, 2024.
• The company will file the amendment to the articles of incorporation with the Department of State of the State of Florida promptly after the Annual Meeting if Proposal II is approved.

Key Dates

Keywords

proxy statement, annual meeting, shareholders, directors, common stock, authorized shares, MSL, P.A., executive compensation, corporate governance, audit committee